https://www.selleckchem.com/pr....oducts/Gefitinib.htm
To observe the clinical therapeutic effect of adjuvant treatment with heat-sensitive moxibustion for coronavirus disease 2019 (COVID-19) of the ordinary type. A total of 42 patients with COVID-19 of the ordinary type were adopted. Shénquè ( CV8) and Tiānshū ( ST25) were selected. Heat-sensitive moxibustion was operated according to the required standard, 40min to 60min each time, once daily. Before and after moxibustion, the improvements in clinical symptoms were evaluated, such as chest oppression, poor appetite, lassitude and negati
Like
Comment
Share
